Adirondack Trust Company’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.39K Hold
16
﹤0.01% 509
2026
Q1
$3.13K Hold
16
﹤0.01% 486
2025
Q4
$2.78K Hold
16
﹤0.01% 491
2025
Q3
$3.05K Hold
16
﹤0.01% 468
2025
Q2
$2.87K Hold
16
﹤0.01% 436
2025
Q1
$2.71K Hold
16
﹤0.01% 438
2024
Q4
$2.41K Hold
16
﹤0.01% 448
2024
Q3
$2.48K Hold
16
﹤0.01% 451
2024
Q2
$2.19K Hold
16
﹤0.01% 458
2024
Q1
$2.13K Buy
+16
New +$2.08K ﹤0.01% 467
2021
Q4
Sell
-50
Closed -$7K 430
2021
Q3
$7K Buy
+50
New +$7.32K ﹤0.01% 329
2019
Q4
Sell
-27
Closed -$3K 349
2019
Q3
$3K Hold
27
﹤0.01% 316
2019
Q2
$3K Hold
27
﹤0.01% 326
2019
Q1
$3K Hold
27
﹤0.01% 317
2018
Q4
$2K Buy
+27
New +$2.53K ﹤0.01% 331

Other funds holding DGX

Adirondack Trust Company's DGX Position: Q2 2026 in Review

Adirondack Trust Company held its Quest Diagnostics (DGX) position steady in Q2 2026 at 16 shares worth $3.39K. The position accounts for ﹤0.01% of the portfolio, ranked #509.

Adirondack Trust Company first reported a position in DGX in Q4 2018 and has held it in 15 quarters since. The position peaked at $7K in Q3 2021. 156 funds tracked by Wall St. Rank hold DGX as of Q2 2026.

  • Adirondack Trust Company held 16 shares of Quest Diagnostics worth $3.39K as of Q2 2026.
  • Adirondack Trust Company left its Quest Diagnostics share count unchanged in Q2 2026.
  • Quest Diagnostics made up ﹤0.01% of Adirondack Trust Company's portfolio in Q2 2026, its #509 holding.
  • Adirondack Trust Company first reported a position in Quest Diagnostics in Q4 2018 and has held it in 15 quarters since.
  • Adirondack Trust Company's Quest Diagnostics position peaked at $7K in Q3 2021.
  • 156 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2026.

Based on Adirondack Trust Company's 13F filing for Q2 2026, filed 16 Jul 2026.